glp-1 class drugs Agonists for Weight Loss: Safe or Risky? Upcoming wave of hormone-based therapies

Artan stres seviyeleri ve ar ilenmi gdalara daha fazla maruz kalma gibi genetik ve evresel faktrler de buna katkda bulunuyor

this drug has recently completed phase 2a clinical trials with promising results in reducing HbA1c without any nausea [50]

There are currently 13 clinical trials investigating GLP-1RAs for PCOS registered with a National Clinical Trial number, targeting various outcomes of GLP-1RAs on PCOS patients, including weight loss, hormonal changes, metabolic health, and reproductive parameters

Br J Pharmacol 166 , 121136, (2012)

doi: 10.1016/b978-0-12-571131-9.50017-7 13 BellGISanchez-PescadorRLaybournPJNajarianRC

The rationale is that two smaller doses produce a more even medication level throughout the week, avoiding the peak-and-trough pattern that creates intense digestive effects early in the week and diminishing effects late in the week